Product description

Zeloglin® cream contains hydroxypropyl chitosan and potassium azeloyl diglycinate, two components which act as film forming and hydrating agents, helping the product to form an elastic film onto the skin, after application and drying, suitable to protect the skin from chemical or physical insults. The two components of the film, saccharidic and lipidic, act in a synergistic way and have a protective activity superior to that of the two components alone, providing a greater hydration to the skin and protection from sudden changes in temperature.

The efficacy of the product is further improved by the presence in the formulation of UV-filters, which provide protection from sunlight, a well-known and very common risk factor for rosacea.

Zeloglin®  cream forms a uniform and invisible film that does not dirty, differently from gels and lotions does not dry, and does not give bothersome sensation, such as oily skin or on the contrary stiff skin, like other rigid film preparations do.

Intended use

Zeloglin® cream is indicated to manage and relieve the signs and symptoms of mild to moderate rosacea such as flushing, erythema (or redness), itching, burning and stinging.

Zeloglin®  cream helps to relieve dry skin by maintaining a moist skin environment, which is beneficial to a healing process while protecting skin from sunlight, external agents and sudden changes of temperature.

It is also useful for protecting skin in other chronic inflammatory conditions of the skin, like leg and face dilation of capillary vessels and for protection and recovery of other facial redness (for example after sun exposure).


  • Do not use if you have any known hypersensitivity to one or more of the ingredients


  • Do not use the product if the packaging is damaged or after expiration date indicated on the tube or the box.
  • Keep out of the sight and reach of children.

Undesirable effects

Uncommon side effects are application site and local irritation reactions, including redness, rash, pruritus, burning sensation, swelling, pain, feeling hot, dry skin, skin tightness or exfoliation. Those effects are mostly due to the sensitive skin of rosacea patients and appear in the first days of application. The effects are generally mild and transient without need to stop treatment.

Any serious incident related to the use of Zeloglin® should be reported to the manufacturer and to the competent health authority in your country.